Search

Viatris Inc

Gesloten

SectorGezondheidszorg

17.82 2.24

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.8

Max

17.96

Belangrijke statistieken

By Trading Economics

Inkomsten

-295M

-119M

Verkoop

240M

3.8B

EPS

0.69

Dividendrendement

2.83

Winstmarge

-3.162

Werknemers

30,000

EBITDA

9.4M

653M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+9.05% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

2.83%

2.25%

Volgende Winsten

5 nov 2026

Volgende dividenddatum

14 dec 2026

Volgende Ex Dividend datum

23 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-890M

20B

Vorige openingsprijs

15.58

Vorige sluitingsprijs

17.82

Nieuwssentiment

By Acuity

100%

0%

300 / 339 Rangschikking in Healthcare

Viatris Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 sep 2026, 22:45 UTC

News

Viatris Inc is seeing a modest increase in after-market trading after filing a lawsuit against Novo Nordisk over its planned generic Wegovy.

24 sep 2026, 20:02 UTC

Viatris Inc is trading higher, reaching a peak cumulative return and positioned above its 20-day moving average during Thursday's session.

23 sep 2026, 20:07 UTC

News

Shares of Viatris Inc declined despite Oppenheimer initiating coverage with an Outperform rating and a $25 price target, amid broader market downward pressure.

22 sep 2026, 22:30 UTC

Viatris Inc is declining in after-market trading, moving lower since Tuesday's close despite peaking above the previous close earlier in the session.

21 sep 2026, 23:01 UTC

Viatris Inc is trading modestly higher in after-market hours, reaching a peak return since Monday's close and staying near the upper end of its one-month range.

18 sep 2026, 21:01 UTC

Viatris Inc. is trading modestly higher in after-market hours, currently positioned above its 20-day moving average and near the upper end of its one-month range.

17 sep 2026, 20:08 UTC

Viatris Inc. shares are up modestly, reaching a peak above the previous close while remaining above the 20-day moving average.

16 sep 2026, 23:16 UTC

Viatris Inc. is trading modestly lower in after-market hours, having experienced unusual volatility after initially rising earlier in the session.

15 sep 2026, 20:07 UTC

Viatris shares are roughly flat as the broader market declines amid a significant drop in the NY Empire State Manufacturing Index and rising oil prices.

14 sep 2026, 20:07 UTC

Viatris Inc's shares are higher today, continuing a gradual increase since Friday's close despite an earlier pullback. No specific news was identified.

11 sep 2026, 21:41 UTC

Shares of Viatris Inc. declined in after-market trading, reflecting a notable dip from earlier highs and a cumulative return of -0.36% since Friday's close.

10 sep 2026, 20:07 UTC

Viatris Inc shares are lower amid a broader market decline, reflecting ongoing economic concerns. The stock has seen five consecutive daily closes lower.

9 sep 2026, 19:36 UTC

News

Viatris shares are lower today despite Leerink Partners initiating coverage with an Outperform rating and a price target of $20.

8 sep 2026, 19:46 UTC

Viatris Inc shares are lower today, influenced by broader market declines and rising Brent crude prices amid geopolitical tensions. No specific company news was identified.

4 sep 2026, 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3 sep 2026, 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2 sep 2026, 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1 sep 2026, 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31 aug 2026, 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28 aug 2026, 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27 aug 2026, 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26 aug 2026, 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25 aug 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24 aug 2026, 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21 aug 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20 aug 2026, 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19 aug 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18 aug 2026, 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17 aug 2026, 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14 aug 2026, 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

Peer Vergelijking

Prijswijziging

Viatris Inc Prognose

Koersdoel

By TipRanks

9.05% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 19.444 USD  9.05%

Hoogste 25 USD

Laagste 13 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Viatris Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

5

Buy

3

Hold

1

Sell

Sentiment

By Acuity

300 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.